As the COVID-19 virus continues to impact our communities, we understand there may be concerns regarding your ability to order and receive important research reagents. New England Biolabs is working diligently to ensure we keep our employees and their families safe, while maintaining our business continuity in support of our many customers around the globe. Our manufacturing and distribution teams continue to be fully operational, and we are working closely with our suppliers and distribution partners to ensure uninterrupted access to our products and technical support. We are also following the guidelines of local and national health organizations in order to mitigate the spread of COVID-19.

NEB’s products are available for research purposes only. However, we are already supplying and supporting customers who are working diligently to develop better diagnostic tools and vaccines for the COVID-19 virus, and are ready to supply additional customers with the reagents they need to validate and develop them as diagnostic tools for lab-based or point-of-care settings.

Select an application to learn more:

COVID_RNAExtraction_Category COVID_VirusDetection_Category



RNA Extraction

Extraction of RNA is often the first step in viral detection assays and has become an increasingly important laboratory technique in the midst of this global pandemic. Though NEB does not offer a kit specifically designed for viral RNA extraction, the Monarch Total RNA Miniprep Kit has been successfully used to extract RNA from various samples including saliva, buccal swabs, and simulated nasopharyngeal samples.  


Monarch® Total RNA Miniprep Kit (NEB #T2010)

This comprehensive kit include reagents for extracting RNA from a wide variety of sample types with a fast and user-friendly workflow.

  • Quickly and easily purify up to 100 µg of high quality total RNA (>20 nt)

  • Purified RNA is suitable for downstream reactions, such as RT-qPCR and library prep for next gen sequencing

  • Elute in as little as 30 µl (RNA samples can be further concentrated following purification using our Monarch RNA Cleanup columns or kits)
COVID_protocol_Icon Protocol for Total RNA Purification from Saliva, Buccal Swabs and Nasopharyngeal Samples

Return to top



Virus Detection

Virus detection often utilizes nucleic acid amplification to identify the presence of specific sequences in SARS-CoV-2 viral RNA. These methods include RT-qPCR for real time quantitation and loop-mediated isothermal amplification (LAMP) for robust amplification performed at a single reaction temperature.



WarmStart® Colorimetric LAMP 2X Master Mix (DNA & RNA) (NEB #M1800)

WarmStart Colorimetric LAMP 2X Master Mix is an optimized formulation of Bst 2.0 WarmStart DNA Polymerase and WarmStart RTx in a special low-buffer reaction solution.The mix contains a visible pH indicator for rapid and easy detection of Loop-Mediated Isothermal Amplification (LAMP) and RT-LAMP reactions.

  • Easily detect amplification with a simple pink-to-yellow color change
  • Set up reactions at room temperature, as WarmStart feature inhibits activity at 25°C
  • Compatible with carryover prevention
COVID_publication_Icon Preprint: Rapid Molecular Detection of SARS-CoV-2 (COVID-19) Virus RNA Using Colorimetric LAMP
COVID_publication_Icon Enhancing Colorimetric LAMP Amplification Speed and Sensitivity with Guanidine Chloride 
Additional citations and EUA protocols featuring Colorimetric LAMP kits


WarmStart LAMP Kit (DNA & RNA) (NEB# E1700)

The WarmStart LAMP Kit contains a blend of Bst 2.0 WarmStart DNA Polymerase and WarmStart RTx for optimal LAMP and RT-LAMP performance. It is compatible with multiple detection methods, including real-time fluorescence detection (when used with included LAMP fluorescent dye), turbidity, and end-point visualization.

Citations and protocols featuring LAMP kits


Luna® RT-qPCR Kits

Luna Universal One-Step RT-qPCR kits offer exceptional sensitivity, reproducibility and RT-qPCR performance. Available for probe- or dye-based detection, Luna kits utilize a novel, thermostable WarmStart RT, which increases reaction specificity. Reaction mixes also contain dUTP, which supports carryover prevention. 

Relevant Luna products include:

COVID_appNote_icon Application note: Explore the latest research in direct detection of SARS-CoV-2 RNA using Luna reagents
Application note: Learn how high throughput qPCR and RT-qPCR workflows are enabled by Beckman Coulter Echo Acoustic Liquid Handling and NEB’s Luna reagents 
Additional citations and EUA protocols featuring Luna kits

Return to top




Sequencing & Epidemiology

In the COVID-19 pandemic, sequencing is enabling scientists, often in unprecedented collaborations, to make rapid advances in epidemiology and surveillance, basic and clinical research, and diagnostics. A fast-growing number of methods are being developed to address these applications, including targeted SARS-CoV-2 sequencing, host genomic sequencing and metagenomic sequencing. 


Products for Oxford Nanopore Technologies® Sequencing

The following reagents are being recommended in a number of third party COVID-19 sequencing protocols, including “PCR tiling of COVID-19 virus” in Oxford Nanopore Technologies’ Nanopore Community, and the ARTIC protocol

COVID_protocol_Icon More information on these and other protocols




Products for Illumina® Sequencing

A number of methods are being developed using the Illumina platform for virus, metagenomic and host sequencing, as well as diagnostics. These include ARTIC-based virus enrichment protocols and novel workflows.

  • NEBNext Ultra II RNA Library Prep Kit for Illumina (NEB #E7770)
  • NEBNext Ultra II Directional RNA Library Prep Kit for Illumina (NEB #E7760)
  • NEBNext Ultra II DNA Library Prep Kit for Illumina (NEB #E7645)
  • NEBNext Ultra II RNA First Strand Synthesis Module (NEB #E7771)
  • NEBNext Ultra II Non-Directional RNA Second Strand Synthesis Module (NEB #E6111)
  • NEBNext rRNA Depletion Kit v2 (Human/Mouse/Rat) (NEB #E7400)
  • LunaScript RT SuperMix Kit (NEB #E3010)
COVID_publication_Icon Additional citations featuring NEBNext products

Return to top





Vaccine Development

mRNA-based vaccines are an emerging alternative to conventional vaccine approaches. Unlike protein-based vaccines, mRNA vaccines involve introduction of an mRNA sequence encoding disease-specific antigens. Once delivered into the cells, they get translated by the cellular machinery, resulting in the synthesis of protein antigens. These antigens are recognized by the immune system, and immune responses are mounted. Successful mRNA vaccines for infectious diseases will prompt protective immunity from possible infection. Several mRNA vaccine candidates are in development for SARS-CoV-2. mRNA vaccines can be rapidly and scalably produced in vitro using enzymes to transcribe and modify mRNA. 


Reagents for mRNA synthesis

NEB’s portfolio of research-grade and GMP-grade* reagents enables bench-scale to commercial-scale mRNA manufacturing, enabling a seamless transition to large-scale therapeutic mRNA manufacturing.

COVID_info_icon Learn more about our GMP-grade in vitro transcription reagents

Return to top





Product Citation Tool

View citations that utilize NEB products using the Product Citation Tool. Refine your search by updating search field and then selecting a filter type. For your convenience, COVID-19 has been selected as a filter on this page.


"GMP-grade" is a branding term NEB uses to describe reagents manufactured at NEB’s Rowley facility. The Rowley facility was designed to manufacture reagents under more rigorous infrastructure and process controls to achieve more stringent product specifications and customer requirements. Reagents manufactured at NEB’s Rowley facility are manufactured in compliance with ISO 9001 and ISO 13485 quality management system standards. However, at this time, NEB does not manufacture or sell products known as Active Pharmaceutical Ingredients (APIs), nor does NEB manufacture its products in compliance with all of the Current Good Manufacturing Practice regulations.

One or more of these products are covered by patents, trademarks and/or copyrights owned or controlled by New England Biolabs, Inc. For more information, please email us at [email protected]. The use of these products may require you to obtain additional third party intellectual property rights for certain applications.



Welcome to the COVID-19 researcher spotlight

Hear from scientists around the world as they discuss publications related to COVID-19, new protocols and techniques for detection and characterization, as well as how the scientific community is coming together to address this pandemic...all in 19 minutes or less!

COVID-19 Rabe Podcast

In this episode of the NEB podcast, Lessons from Lab and Life, hear from Brian Rabe of Harvard Medical School about his work applying RT-LAMP to develop a fast SARS-CoV-2 diagnostic assay.

Listen to Podcast

Doing COVID-19 related research?

Let us know what you are working on, so we can keep you informed on new COVID-19 related products and publications available from NEB.

Stay Informed

Interested in larger quantities?

Requests to obtain any of these products in larger quantities in connection with the COVID-19 crisis should be forwarded to [email protected].

For more general inquiries or questions, please feel free to contact us at [email protected].